Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 25

Cited In for PubMed (Select 12821544)

1.

Impact of antidepressants use on risk of myocardial infarction: A systematic review and meta-analysis.

Undela K, Parthasarathi G, John SS.

Indian J Pharmacol. 2015 May-Jun;47(3):256-62. doi: 10.4103/0253-7613.157112.

2.

Antidepressant use and risk of coronary heart disease: meta-analysis of observational studies.

Oh SW, Kim J, Myung SK, Hwang SS, Yoon DH.

Br J Clin Pharmacol. 2014 Oct;78(4):727-37. doi: 10.1111/bcp.12383.

PMID:
24646010
3.

Acute fluoxetine treatment induces slow rolling of leukocytes on endothelium in mice.

Herr N, Mauler M, Witsch T, Stallmann D, Schmitt S, Mezger J, Bode C, Duerschmied D.

PLoS One. 2014 Feb 10;9(2):e88316. doi: 10.1371/journal.pone.0088316. eCollection 2014.

4.
5.

Teaching an old drug new tricks: can paroxetine ease the burden of cardiovascular disease in diabetes?

Wheatcroft SB.

Diabetes. 2013 Mar;62(3):698-700. doi: 10.2337/db12-1530. No abstract available.

6.

Cell-based screening identifies paroxetine as an inhibitor of diabetic endothelial dysfunction.

Gerö D, Szoleczky P, Suzuki K, Módis K, Oláh G, Coletta C, Szabo C.

Diabetes. 2013 Mar;62(3):953-64. doi: 10.2337/db12-0789. Epub 2012 Dec 7.

7.

Primum non nocere: an evolutionary analysis of whether antidepressants do more harm than good.

Andrews PW, Thomson JA Jr, Amstadter A, Neale MC.

Front Psychol. 2012 Apr 24;3:117. doi: 10.3389/fpsyg.2012.00117. eCollection 2012.

8.

Selective serotonin reuptake inhibitor use is associated with right ventricular structure and function: the MESA-right ventricle study.

Ventetuolo CE, Barr RG, Bluemke DA, Jain A, Delaney JA, Hundley WG, Lima JA, Kawut SM.

PLoS One. 2012;7(2):e30480. doi: 10.1371/journal.pone.0030480. Epub 2012 Feb 17.

9.

Antidepressants, antiplatelets and bleeding: one more thing to worry about?

Juurlink DN.

CMAJ. 2011 Nov 8;183(16):1819-20. doi: 10.1503/cmaj.111576. Epub 2011 Oct 3. No abstract available.

10.

Antidepressant use and risk of adverse outcomes in older people: population based cohort study.

Coupland C, Dhiman P, Morriss R, Arthur A, Barton G, Hippisley-Cox J.

BMJ. 2011 Aug 2;343:d4551. doi: 10.1136/bmj.d4551.

11.

Depression in vascular pathologies: the neurologist's point of view.

Moretti R, Bernobich E, Esposito F, Torre P, Antonello RM, De Angelis L, Bellini G.

Vasc Health Risk Manag. 2011;7:433-43. doi: 10.2147/VHRM.S20147. Epub 2011 Jul 12.

12.

The effect of selective serotonin re-uptake inhibitors on the risk of myocardial infarction in a cohort of patients with depression.

Kimmel SE, Schelleman H, Berlin JA, Oslin DW, Weinstein RB, Kinman JL, Sauer WH, Lewis JD.

Br J Clin Pharmacol. 2011 Sep;72(3):514-7. doi: 10.1111/j.1365-2125.2011.04008.x.

13.

Platelets and cardiac arrhythmia.

de Jong JS, Dekker LR.

Front Physiol. 2010 Dec 30;1:166. doi: 10.3389/fphys.2010.00166. eCollection 2010.

14.

Antidepressant medication use and future risk of cardiovascular disease: the Scottish Health Survey.

Hamer M, Batty GD, Seldenrijk A, Kivimaki M.

Eur Heart J. 2011 Feb;32(4):437-42. doi: 10.1093/eurheartj/ehq438. Epub 2010 Nov 30. Erratum in: Eur Heart J. 2013 Oct;34(40):3160. David Batty, G [corrected to Batty, G David].

15.

Depression following thrombotic cardiovascular events in elderly medicare beneficiaries: risk of morbidity and mortality.

Blanchette CM, Simoni-Wastila L, Shaya FT, Orwig D, Noel J, Stuart B.

Cardiol Res Pract. 2009;2009:194528. doi: 10.4061/2009/194528. Epub 2009 Dec 22.

16.

Possible Role of Platelet GluR1 Receptors in Comorbid Depression and Cardiovascular Disease.

Chen H.

Cardiovasc Psychiatry Neurol. 2009;2009:424728. doi: 10.1155/2009/424728. Epub 2009 Aug 16.

17.
18.
19.

Antidepressant use, depression, and survival in patients with heart failure.

O'Connor CM, Jiang W, Kuchibhatla M, Mehta RH, Clary GL, Cuffe MS, Christopher EJ, Alexander JD, Califf RM, Krishnan RR.

Arch Intern Med. 2008 Nov 10;168(20):2232-7. doi: 10.1001/archinte.168.20.2232.

20.

How the serotonin story is being rewritten by new gene-based discoveries principally related to SLC6A4, the serotonin transporter gene, which functions to influence all cellular serotonin systems.

Murphy DL, Fox MA, Timpano KR, Moya PR, Ren-Patterson R, Andrews AM, Holmes A, Lesch KP, Wendland JR.

Neuropharmacology. 2008 Nov;55(6):932-60. doi: 10.1016/j.neuropharm.2008.08.034. Epub 2008 Sep 11. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk